# Phase 107: Gap Resolution Report & Delivery - Context

**Gathered:** 2026-06-15
**Status:** Ready for planning

<domain>
## Phase Boundary

Compile all v3.2 (and referenced v3.1) investigation findings into a self-contained RMarkdown HTML report organized by gap number, generate a delivery manifest listing all v3.1+v3.2 output files with validation, and update the meeting notes to mark resolved gaps with inline resolution notes and remove completed Gerard action items. Three deliverables: RMarkdown report, manifest script, updated meeting notes.

</domain>

<decisions>
## Implementation Decisions

### Report Structure (REPORT-01)
- **D-01:** Organized by gap number (G1-G15) — sections mapped directly to meeting note gap items so the team can trace findings back to the original questions.
- **D-02:** Covers v3.2 resolved gaps only: G1 (CONDITION linkage, v3.1), G2 (broadened drug grouping, v3.1), G3 (co-admin analysis, v3.1), G4 (HL+NHL overlap), G5 (pre-dx radiation), G8 (Ethna), G10 (transplant code), G11 (SCT codes), G15 (death dates, v3.1), plus TABLE-1/TABLE-2 delivery.
- **D-03:** Each gap section contains a 1-2 paragraph finding summary plus the most important table from the investigation xlsx — concise for meeting review.
- **D-04:** Data sourced by reading xlsx output files via readxl::read_excel() — report is a presentation layer over existing outputs, no re-execution of investigation scripts.
- **D-05:** Executive summary section at the top listing each gap investigated and its one-line resolution.

### Presentation Quality
- **D-06:** Clean internal report — professional but not publication-quality. Clean tables via kableExtra, section headers, floating table of contents, readable fonts. Meeting-appropriate without overengineering.
- **D-07:** Tables rendered with kableExtra static HTML — no JavaScript dependencies, renders cleanly in self-contained HTML, prints well.
- **D-08:** Self-contained HTML (html_document with self_contained: true) so the single .html file can be shared directly without supporting files.

### Meeting Notes Update (REPORT-03)
- **D-09:** Resolved gaps marked with inline resolution notes below each gap item — e.g., G5 retains original text plus adds a resolution line with phase reference and key finding.
- **D-10:** "Stale items" = completed Gerard action items only. Remove Gerard's action items that are now complete from the v3.1/v3.2 work. Leave other people's (Amy, Erin, Raymond, Sebastian) action items untouched.

### Delivery Manifest (REPORT-02)
- **D-11:** R script that generates an xlsx listing of all v3.1 + v3.2 output files with columns: filename, description, phase, date modified, size.
- **D-12:** Manifest validates file existence — checks that each expected file is present and flags any missing files.
- **D-13:** Scope covers all new outputs from v3.1 (Phases 100-103: condition linkage, broadened drug grouping, co-admin analysis, death date summary) and v3.2 (Phases 104-107: pre-dx treatments, secondary malignancy, code verification, HL+NHL overlap, Tableau tables, plus the report itself).

### Claude's Discretion
- Script numbering (next available in appropriate decade)
- RMarkdown YAML header details (theme, code_folding, etc.)
- Exact kableExtra styling (striped rows, hover, etc.)
- Column selection from xlsx files for display tables
- Resolution note wording for each gap
- Which Gerard action items are confirmed complete vs uncertain
- R/88 smoke test additions for new scripts

</decisions>

<canonical_refs>
## Canonical References

**Downstream agents MUST read these before planning or implementing.**

### Meeting Notes (gap definitions and action items)
- `pecan_lymphoma_meeting_notes_combined.md` -- Section 4 defines G1-G15 gap items; Section 5 defines per-person action items. Primary source for gap resolution mapping and stale item identification.

### Investigation Outputs (report data sources)
- `output/condition_linkage_investigation.xlsx` -- v3.1 Phase 100: CONDITION table cancer linkage results (G1)
- `output/drug_grouping_instances.xlsx` -- v3.1 Phase 101: Broadened drug grouping with cancer_linked flag (G2)
- `output/co_administration_analysis.xlsx` -- v3.1 Phase 102: Single-agent co-admin patterns (G3)
- `output/death_date_summary.xlsx` -- v3.1 Phase 103: Death date cross-tab (G15)
- `output/pre_diagnosis_treatments.xlsx` -- v3.2 Phase 104: Pre-dx treatment flagging (G5)
- `output/secondary_malignancy_table.xlsx` -- v3.2 Phase 104: Secondary malignancy with 7-day gap (related to G5)
- `output/code_verification.xlsx` -- v3.2 Phase 105: Ethna/transplant/SCT code verification (G8, G10, G11)
- `output/hl_nhl_overlap_validation.xlsx` -- v3.2 Phase 105: HL+NHL dual-code validation (G4)
- `output/tableau_table1_encounter_cancer_codes.xlsx` -- v3.2 Phase 106: TABLE-1 (Tableau)
- `output/tableau_table2_chemo_drugs_by_class.xlsx` -- v3.2 Phase 106: TABLE-2 (Tableau)

### Existing Report Generation Patterns
- `R/89_generate_reference_manual.R` -- Reference manual generator pattern (file scanning, markdown generation)
- `R/74_generate_documentation.R` -- Variable documentation generation pattern

### Requirements
- `.planning/REQUIREMENTS.md` -- REPORT-01, REPORT-02, REPORT-03 requirement definitions

### Prior Phase Contexts
- `.planning/phases/104-treatment-timing-investigations/104-CONTEXT.md` -- TIMING-01/02 decisions
- `.planning/phases/105-code-overlap-verification/105-CONTEXT.md` -- CODE-01/02/03, OVERLAP-01 decisions
- `.planning/phases/106-tableau-ready-data-tables/106-CONTEXT.md` -- TABLE-01/02 decisions

</canonical_refs>

<code_context>
## Existing Code Insights

### Reusable Assets
- **R/89_generate_reference_manual.R**: File scanning and markdown generation pattern — can inform the manifest script's approach to inventorying output files.
- **R/74_generate_documentation.R**: Template-based document generation pattern.
- **openxlsx2 workbook pattern**: wb_workbook() -> add_worksheet() -> add_data() -> save(). Established across investigation scripts for manifest xlsx output.
- **readxl::read_excel()**: Available for reading xlsx files into the RMarkdown report.
- **kableExtra**: Not yet used in the project — new dependency for report table rendering.

### Established Patterns
- Investigation script pattern: Section-based structure with console logging, loads existing artifacts, produces styled xlsx output.
- Styled xlsx: dark header row (FF374151), white bold text, freeze panes, autofit column widths.
- Console logging with glue: section headers, row counts, summary statistics.
- Input validation with checkmate assertions.

### Integration Points
- **Reads**: All v3.1/v3.2 xlsx output files (listed in canonical refs above)
- **Reads**: `pecan_lymphoma_meeting_notes_combined.md` for gap definitions
- **Writes**: `R/37_gap_resolution_report.Rmd` or similar (new RMarkdown file)
- **Writes**: `output/gap_resolution_report.html` (rendered report)
- **Writes**: `R/38_delivery_manifest.R` or similar (manifest script)
- **Writes**: `output/delivery_manifest.xlsx` (manifest output)
- **Modifies**: `pecan_lymphoma_meeting_notes_combined.md` (gap resolutions + stale item removal)
- **Modifies**: `R/88_smoke_test_comprehensive.R` (new validation sections)

</code_context>

<specifics>
## Specific Ideas

- This is the first RMarkdown in the project — keep infrastructure simple (html_document, no custom templates)
- kableExtra is a new dependency — needs to be available on HiPerGator (standard CRAN package, should be fine)
- Report should be self-contained HTML so it can be emailed or shared on Teams without a webserver
- Meeting notes resolution format: original gap text preserved with resolution note appended below, e.g., "RESOLVED (v3.2 Phase 104): [one-line finding]"
- Manifest file descriptions should be human-readable (for Amy) — not technical script names but plain English descriptions of what each file contains
- v3.1 investigation outputs need to be identified and verified — they were created in Phases 100-103

</specifics>

<deferred>
## Deferred Ideas

None -- discussion stayed within phase scope

</deferred>

---

*Phase: 107-gap-resolution-report-delivery*
*Context gathered: 2026-06-15*
